NCT02948881View on ClinicalTrials.gov

A Study To Assess The Quality Of Bone In Patients Taking Oral Ibandronate Versus Placebo

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Osteoporosis
Interventions
DRUG

ibandronate

Trial Locations (15)

10993

GSK Investigational Site, West Haverstraw

16635

GSK Investigational Site, Duncansville

20817

GSK Investigational Site, Bathesda

30033

GSK Investigational Site, Decatur

30308

GSK Investigational Site, Atlanta

33143

GSK Investigational Site, Miami

33156

GSK Investigational Site, Miami

33407

GSK Investigational Site, West Palm Beach

46202

GSK Investigational Site, Indianapolis

48532

GSK Investigational Site, Flint

80227

GSK Investigational Site, Lakewood

80304

GSK Investigational Site, Boulder

87106

GSK Investigational Site, Albuquerque

91786

GSK Investigational Site, Upland

04401

GSK Investigational Site, Bangor

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY